文献速递神经核医学肿瘤 PET/CT

68Ga-PSMA-11 PET/CT在胶质瘤成像中的应用:一项先导研究

Utility of 68Ga-PSMA-11 PET/CT in Imaging of Glioma-A Pilot Study.
PubMed 文献 · Clin Nucl Med · 2018-01-01

该先导研究纳入2个中心的15例胶质瘤患者,评估68Ga-PSMA-11 PET/CT成像胶质瘤的可行性。10例疑似胶质母细胞瘤复发患者中9例扫描阳性且经组织病理学证实为真性复发,扫描阴性者随访无临床或影像学疾病证据。作者认为68Ga-PSMA-11脑PET/CT在复发胶质瘤评估中似乎有前景。

要点

  • 10例疑似复发胶质母细胞瘤中9例68Ga-PSMA-11 PET/CT阳性,均经组织病理学证实为真性复发。
  • 1例扫描阴性者随访无临床或影像学疾病证据。
  • 真性疾病者病灶靶/本底比值(TBR)显著高于无疾病者。

核心结论

  • 在胶质瘤评估中,68Ga-PSMA-11 PET/CT脑成像是潜在有用的成像工具。
  • 68Ga-PSMA-11脑PET/CT在复发胶质瘤评估中似乎有前景。
  • 正常脑实质缺乏68Ga-PSMA-11生理性摄取,导致高TBR值,从而更好地显示胶质瘤病灶。

研究设计与样本

  • 来自2个中心的15例胶质瘤患者纳入该先导研究。
  • 10例为疑似复发的胶质母细胞瘤治疗病例;2例为评估脑内占位性病变性质(原发灶/转移灶);3例为术后即刻、放疗前成像。
  • 以对侧小脑摄取为背景计算脑病灶的靶/本底比值(TBR)。

主要发现

  • 10例疑似复发者中9例扫描阳性,随后行手术,组织病理学证实为真性复发。
  • 扫描阴性的1例在随访中临床或影像学均未发现疾病证据。
  • 其余病例中,68Ga-PSMA-11脑扫描可明确识别疾病存在与否,并与组织病理学或其他影像学相关。
  • 除视觉评估外,病灶TBR定量评估显示真性疾病者TBR值显著高于无疾病者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Imaging of gliomas remains challenging. The aim of the study was to assess the feasibility of using Ga-PSMA-11 PET/CT for imaging gliomas. METHODS: Fifteen patients with glioma from 2 centers were included in the study. Ten patients were treated cases of glioblastoma with suspected recurrence. Two patients were sent for assessing the nature (primary lesion/metastasis) of space-occupying lesion in the brain; 3 patients were imaged immediately after surgery and before radiotherapy. Target-to-background ratios (TBR) for the brain lesions were calculated using contralateral cerebellar uptake as background. RESULTS: Among the 10 cases with suspected recurrence, scan was positive in 9, subsequent surgery was done, and histopathology proved it to be true recurrence. In the scan-negative case on follow-up, no evidence of disease could be made clinically or radiologically. Among the other cases the presence or absence of disease could be unequivocally identified on the Ga-PSMA-11 brain scan and correlated with the histopathology or other imaging. Apart from the visual assessment quantitative assessment of the lesions with TBR also showed a significantly high TBR value for those with true disease compared with those with no disease. CONCLUSIONS: In the evaluation of gliomas, Ga-PSMA-11 PET/CT brain imaging is a potentially useful imaging tool. The use of Ga-PSMA-11 brain PET/CT in evaluation of recurrent glioma seems promising. Absence of physiological uptake of Ga-PSMA-11 in the normal brain parenchyma results in high TBR values and consequently better visualization of glioma lesions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sasikumar A, Kashyap R, Joy A, et al. Utility of 68Ga-PSMA-11 PET/CT in Imaging of Glioma-A Pilot Study. Clin Nucl Med. 2018. PMID: 29939953. doi:10.1097/RLU.0000000000002175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。